Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.800
-0.170 (-4.28%)
At close: May 11, 2026, 4:00 PM EDT
3.700
-0.100 (-2.63%)
After-hours: May 11, 2026, 6:27 PM EDT

Whitehawk Therapeutics Revenue

In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.

Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
23
Market Cap
187.83M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.15M-18.84M-72.50%
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 2019---
Dec 31, 201820.16M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics149.50M
Karyopharm Therapeutics146.07M
Precision BioSciences45.07M
Atrium Therapeutics18.62M
Tonix Pharmaceuticals Holding13.11M
Caribou Biosciences11.20M
InflaRx33.82K
Revenue Rankings

WHWK News

More News